Adverse Effects and Functional Outcome after Salvage Lymph Node Dissection in Prostate Cancer
SLND is a treatment option in selected patients with nodal-recurrent prostate cancer with considerable complication rates and possible functional impairments that need to be discussed with the patient when balancing the indication for this metastasis-directed treatment option.
Authors
- August Sigle (ORCID: https://orcid.org/0000-0001-6857-8149)
- Simon K. B. Spohn (ORCID: https://orcid.org/0000-0003-2727-8005)
- Larissa Lang
- Ruth Himmelsbach (ORCID: https://orcid.org/0009-0001-2178-5586)
- Markus Grabbert (ORCID: https://orcid.org/0000-0002-7059-6124)
- Anca-Ligia Grosu (ORCID: https://orcid.org/0000-0003-2255-2255)
- Julia Franz (ORCID: https://orcid.org/0000-0002-0471-2764)
- Christian Gratzke
- Moritz Weishaar
- Cordula A. Jilg (ORCID: https://orcid.org/0000-0001-5823-5679)
- Constantinos Zamboglou (ORCID: https://orcid.org/0000-0002-7849-7550)
- Wolfgang Schultze‐Seemann
Institutions
- University of Freiburg (DE)
- University Medical Center Freiburg (DE)
Publication Details
- Journal
- Oncology Research and Treatment
- Published
- 2025-10-23
- DOI
- https://doi.org/10.1159/000549126
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00